While the FDA has approved Ozempic as a diabetes drug, the FDA has not approved using it for weight loss
Because MEPS uses a repeated cross-sectional design, the study described population-level changes and did not follow individual patients or demonstrate medication switching
All subjects received up to 10 standardized cognitive-behavioral therapy sessions
Lunch Quinoa bowl with black beans, roasted sweet potatoes, kale, and avocado Water with lime A hearty bowl filled with grains, veggies, and a healthy fat from avocado, this lunch is colorful and delicious
Dont try to use your semaglutide past its expiration date
Neuropsychiatric safety should be a key consideration in any randomized clinical trial and clinical risk-benefit assessment associated with GLP1 anti-obesity medications and the data provided here contribute to thoughtful and objective decision-making and dialogue between patients and clinicians